Publications

Export 33 results:
Author Title [ Type(Asc)] Year
Filters: Author is Bruno Giros  [Clear All Filters]
Journal Article
Xu Y, Lu Y, Xu P, Mangieri LR, Isingrini E, Xu Y, Giros B, Tong Q.  2017.  VMAT2-Mediated Neurotransmission from Midbrain Leptin Receptor Neurons in Feeding Regulation.. eNeuro. 4(3)
Erdozain AM, De Gois S, Bernard V, Gorgievski V, Pietrancosta N, Dumas S, Macedo CE, Vanhoutte P, Ortega JE, J Meana J et al..  2017.  Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.. Neuropsychopharmacology.
Isingrini E, Perret L, Rainer Q, Sagueby S, Moquin L, Gratton A, Giros B.  2016.  Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.. J Psychiatry Neurosci. 41(3):169-81.
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu AP, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM et al..  2019.  Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration.. Sci Rep. 9(1):7850.
Isingrini E, Perret L, Rainer Q, Amilhon B, Guma E, Tanti A, Martin G, Robinson J, Moquin L, Marti F et al..  2016.  Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons.. Nat Neurosci. 19(4):560-3.
Fasano C, Rocchetti J, Pietrajtis K, Zander J-F, Manseau F, Sakae DY, Marcus-Sells M, Ramet L, Morel LJ, Carrel D et al..  2017.  Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells.. Front Cell Neurosci. 11:140.
Cutando L, Puighermanal E, Castell L, Tarot P, Bertaso F, Bonnavion P, d'Exaerde Ade Kerchov, Isingrini E, Galante M, Dallérac G et al..  2020.  Regulation of GluA1 phosphorylation by d-amphetamine and methylphenidate in the cerebellum.. Addict Biol. :e12995.
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, Elgbeili G, Courcot B, Mechawar N, Chakravarty MM et al..  2018.  Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor.. Neuroimage. 176:226-238.
Rocchetti J, Isingrini E, Dal Bo G, Sagheby S, Menegaux A, Tronche F, Levesque D, Moquin L, Gratton A, Wong TPan et al..  2015.  Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus.. Biol Psychiatry. 77(6):513-25.
Bimpisidis Z, König N, Stagkourakis S, Zell V, Vlcek B, Dumas S, Giros B, Broberger C, Hnasko TS, Wallén-Mackenzie Å.  2019.  The NeuroD6 Subtype of VTA Neurons Contributes to Psychostimulant Sensitization and Behavioral Reinforcement.. eNeuro. 6(3)
Torres-Platas SG, Comeau S, Rachalski A, Dal Bo G, Cruceanu C, Turecki G, Giros B, Mechawar N.  2014.  Morphometric characterization of microglial phenotypes in human cerebral cortex.. J Neuroinflammation. 11:12.
Bhardwaj SK, Cui Q, Moquin L, Gratton A, Giros B, Srivastava LK.  2021.  Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.. Neuropharmacology. 184:108440.
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
Bai J, Blot K, Tzavara E, Nosten-Bertrand M, Giros B, Otani S.  2014.  Inhibition of dopamine transporter activity impairs synaptic depression in rat prefrontal cortex through over-stimulation of D1 receptors.. Cereb Cortex. 24(4):945-55.
Giguère N, Delignat-Lavaud B, Herborg F, Voisin A, Li Y, Jacquemet V, Anand-Srivastava M, Gether U, Giros B, Trudeau L-É.  2019.  Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.. PLoS Genet. 15(8):e1008352.
Blum ID, Zhu L, Moquin L, Kokoeva MV, Gratton A, Giros B, Storch K-F.  2014.  A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal.. Elife. 3
Crépeaux G, Eidi H, David M-O, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J.  2015.  Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections.. J Inorg Biochem. 152:199-205.
Nair AG, Castro LRV, Khoury MEl, Gorgievski V, Giros B, Tzavara ET, Hellgren-Kotaleski J, Vincent P.  2019.  The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.. Neuropharmacology. 146:74-83.
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Isingrini E, Guinaudie C, Perret LC, Rainer Q, Moquin L, Gratton A, Giros B.  2017.  Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.. Sci Rep. 7(1):12432.
Pilorge M, Fassier C, Le Corronc H, Potey A, Bai J, De Gois S, Delaby E, Assouline B, Guinchat V, Devillard F et al..  2015.  Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism.. Mol Psychiatry.
Doly S, Shirvani H, Gäta G, Meye FJ, Emerit M-B, Enslen H, Achour L, Pardo-Lopez L, Yang S-K, Armand V et al..  2015.  GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper.. Mol Psychiatry.
Cavarec F, Krauss P, Witkowski T, Broisat A, Ghezzi C, De Gois S, Giros B, Depaulis A, Deransart C.  2019.  Early reduced dopaminergic tone mediated by D3 receptor and dopamine transporter in absence epileptogenesis.. Epilepsia. 60(10):2128-2140.
Petrelli F, Dallérac G, Pucci L, Calì C, Zehnder T, Sultan S, Lecca S, Chicca A, Ivanov A, Asensio CS et al..  2018.  Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.. Mol Psychiatry.
C Filho DDe Magalha, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C, Nosten-Bertrand M, Billard J-M, Blaise A, Tronche F et al..  2017.  Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.. J Cereb Blood Flow Metab. 37(2):396-412.

Pages